Jennifer Williams
Family · Nashville, TNNPI 1962686592
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $146,591 of the $213,037 with a category attached, or 68.8%. Corcept Therapeutics accounts for 98.0% of it on its own, with 28 other manufacturers making up the rest. Reporting peaked in 2023 at $75,225 and has fallen 99.5% since, to $406 in 2025. Among family clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 550 payments — averaging $387.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Corcept Therapeutics$209K
- Novo Nordisk$843
- AbbVie$560
- Lilly USA, LLC$485
- AstraZeneca$459
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$347
- plus $2K from 23 others
What the payments were for
- Consulting fees$11,8006%
- Speaking & faculty fees$146,59169%
- Travel & lodging$43,38420%
- Food & beverage$11,1755%
- Education$870%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Corcept Therapeutics | 312 | $208,802 |
| Novo Nordisk | 46 | $843 |
| AbbVie(2 entities) | 32 | $560 |
| Lilly USA, LLC | 33 | $485 |
| AstraZeneca | 24 | $459 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 16 | $347 |
| Abbott | 12 | $224 |
| Johnson & Johnson | 13 | $212 |
| Boehringer Ingelheim | 9 | $149 |
| Exact Sciences | 6 | $106 |
| Sumitomo Pharma America, Inc. | 6 | $91 |
| Merck | 5 | $90 |
| Pfizer | 5 | $71 |
| Dexcom, Inc. | 3 | $64 |
| Teva Pharmaceuticals USA, Inc. | 2 | $60 |
| Sanofi-aventis U.S. LLC | 4 | $59 |
| Neurocrine Biosciences, Inc. | 2 | $53 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $48 |
| Otsuka America Pharmaceutical, Inc. | 1 | $46 |
| Eisai Inc. | 3 | $45 |
| Xeris Pharmaceuticals, Inc. | 2 | $39 |
| Esperion Therapeutics, Inc. | 2 | $37 |
| Amgen | 2 | $34 |
| GSK | 2 | $24 |
| Zealand Pharma US, Inc. | 1 | $20 |
| Ascensia Diabetes Care US Inc. | 1 | $19 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $19 |
| Insulet Corporation | 1 | $17 |
| Biogen | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$213,037 in reported general payments places this provider in the 95th percentile of 6,706 family providers in Tennessee.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 18 | $21,954 |
| TrulicityDulaglutide | 15 | $17,917 |
| EliquisApixaban | 15 | $9,773 |
| FarxigaDapagliflozin Propanediol | 11 | $8,004 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 11 | $6,880 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 12 | $1,729 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 25 | $644 |
| Omeprazole | 25 | $461 |
| Rosuvastatin Calcium | 35 | $367 |
| Atorvastatin Calcium | 40 | $365 |
| Pantoprazole Sodium | 19 | $327 |
| Fluticasone Propionate | 15 | $283 |
| Gabapentin | 31 | $220 |
| Amlodipine Besylate | 46 | $209 |
| Losartan Potassium | 19 | $191 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $843 | $21,95418 claims |
| Lilly USA, LLCTrulicity | $485 | $17,91715 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $459 | $14,88422 claims |
| PfizerEliquis | $71 | $9,77315 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 6,706 family providers in Tennessee.
Other family in Nashville
- Tamera ThoenerNashville$254K
- Lori LankfordNashville$148K
- Melissa RikalNashville$144K
- Nicole DelliseNashville$67K
- Lesley BallanceNashville$63K
- Jeffrey WoodsNashville$38K
- Courtney HavillNashville$35K
- Collette UtleyNashville$28K
- Stacy BrownMt Juliet$719K
- Dana WebberKnoxville$499K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.